Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gemini Space Station Inc (GEMI) vs Illumina, Inc. (ILMN) Price & Performance

Gemini Space Station IncTrade
Illumina, Inc.Trade

Price performance (Past 24H)

Key statistics

Gemini Space Station Inc vs Illumina, Inc. — how do they compare? Gemini Space Station Inc trades at $4.46 (market cap $590.44M), while Illumina, Inc. trades at $189.3 (market cap $28.32B). The key difference: Illumina, Inc. is far larger — about 48× Gemini Space Station Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals.

GEMIILMN
Market Cap
$590.44M$28.32B
Sector
TechnologyHealth
52-Week High
$32.52$194.33
52-Week Low
$3.91$91.00
Enterprise Value
$580.43M$29.70B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gemini Space Station Inc

No Aura AI signal available yet.

Illumina, Inc.

Illumina (ILMN) trades at $188.27, down 1.53% on the day, yet maintains a strong technical and fundamental posture. The stock is in a bullish trend, supported by consistent earnings beats, robust profitability margins, and positive analyst sentiment. Recent news highlights strong momentum in 2026, driven by sequencing demand and new product launches, positioning the company for growth despite competitive pressures.

The outlook for ILMN is positive, with earnings growth and market leadership in genomics offering upside potential. Key risks include intensifying competition from new entrants like Roche and execution challenges in a dynamic healthcare landscape. Investor sentiment remains buoyant, but vigilance on competitive threats and margin sustainability is warranted for sustained performance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gemini Space Station Inc

Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.

Read more on GEMI

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN